Post-hospitalisation Nutritional Support and Gait Speed in COPD
NCT ID: NCT02261350
Last Updated: 2015-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
22 participants
INTERVENTIONAL
2014-01-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
NCT01507415
Activity, Balance and COPD (ABCOPD)
NCT04006015
The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease
NCT04202991
Home Balance Pilot for Fall Reduction in COPD
NCT02695342
Understanding Balance Impairment in COPD
NCT05984498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Food Fortification
Food Fortification
Food fortification
Oral Nutritional Supplements
Oral Nutritional Supplements - Fortisip Compact
Oral Nutritional Supplements
Usual Care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Food fortification
Oral Nutritional Supplements
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients at moderate or severe risk of malnutrition
* Adults over the age of 40
* Hospitalised with an AECOPD
Exclusion Criteria
* Inability to swallow or difficulty liquids
* Lactose intolerance, galactosaemia, cow's milk protein allergy or intolerance
* Co-existing active cancer, progressive neurological condition or active GI disorder.
* Receiving palliative care with expectation of death within 3 months
* Cognitive dysfunction or unable to consent
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Research Council
OTHER_GOV
The Hillingdon Hospitals NHS Foundation Trust
OTHER_GOV
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Man, PhD FRCP
Role: PRINCIPAL_INVESTIGATOR
Royal Brompton & Harefield NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hillingdon Hospital NHS Foundation Trust
Uxbridge, Middlesex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013LF004H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.